Celldex Therapeutics buy Barclays PLC
Start price
15:15
/
50%
€29.16
Target price
20.04.27
€38.28
Performance (%)
0.00%
Price
08:14
?
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC is currently unchanged from the start price. This prediction currently runs until 20.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 0.00% |
| iShares Core DAX® | 3,59 % |
| iShares Nasdaq 100 | 5,81 % |
| iShares Nikkei 225® | 4,08 % |
| iShares S&P 500 | 4,14 % |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) was upgraded by Barclays PLC from "underweight" to "overweight". They now have a $45.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
35.32%
08:14
08:14
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
41.83%
08:14
08:14
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
33.19%
08:14
08:14